S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial-Reference-Cited by-同舟云学术

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

Published:2012-11 Issue:11 Volume:13 Page:1125-1132
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Hong Yong Sang,Park Young Suk,Lim Ho Yeong,Lee Jeeyun,Kim Tae Won,Kim Kyu-pyo,Kim Sun Young,Baek Ji Yeon,Kim Jee Hyun,Lee Keun-Wook,Chung Ik-Joo,Cho Sang-Hee,Lee Kyung Hee,Shin Sang Joon,Kang Hye Jin,Shin Dong Bok,Jo Sook Jung,Lee Jae Won

Funder

Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer;Cassidy;J Clin Oncol,2004

2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

3. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results;Cassidy;Br J Cancer,2011

4. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

5. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study;Rothenberg;Ann Oncol,2008

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall survival with non-proportional hazards in first-line treatment for patients with metastatic colorectal cancer: Systematic review and network meta-analysis;Heliyon;2024-08

2. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases;Frontiers in Pharmacology;2024-07-26

3. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials;BMC Cancer;2024-07-24

4. Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial;Journal of Clinical Oncology;2024-05-20

5. Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001);Cancer Chemotherapy and Pharmacology;2024-02-19